Seeking Alpha

Shares of Depomed (DEPO) get clobbered in the post trading session after the company says...

Shares of Depomed (DEPO) get clobbered in the post trading session after the company says top-line results from its Phase 3 trial evaluating the efficacy and safety of Serada, a drug for menopausal hot flashes, missed on a key secondary endpoint evaluation. Shares -24% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)